NEW YORK, April 4 /PRNewswire-FirstCall/ -- Instacare Corp., (OTC Bulletin Board: ISCR) a leading Wi-Fi PDA technology provider to the lodging industry, the developer of patent-pending technologies for e-health and EMR applications and the distributor of life-saving prescription drugs and diagnostics, today provided several meaningful announcements. Instacare has announced the implementation of a series of Supply Chain medical products agreements through MedAssets Healthcare Supply Chain, one of the nation's largest and most prestigious medical contract buying and group discount organizations, and Invacare Supply Group, a division of the Invacare Corporation. These buying arrangements position Instacare and its Medicius and PharmaTech subsidiaries to immediately channel a portfolio of products into the $12+ billion worldwide ostomy and the $4+ billion chronic wound care health sectors. Instacare will initially distribute ostomy and wound care products from five separate companies that collectively comprise more than 60% of the North American markets' current revenue. "This is the first in an expected series of related announcements concerning new distribution, expanded product lines and incremental customer agreements. These arrangements and the additional impending contracts are the result of focused resource allocation and targeted efforts over the past nine months. The doubling of our customer and patient user base, the expanded new markets and enhanced product lines are the culmination of our efforts to persuade these large and diverse entities of the added value derived from our medical technology driven distribution model," commented Keith Berman, Principal Executive Officer of Instacare. These new arrangements will also provide the company with expanded lines of diabetic diagnostic products, medical test kit products and other market related products that are all part of Instacare's chronic illness distribution focus. The Company will furnish additional information related to this arrangement in its 2007 guidance scheduled to be released on or about April 24, 2007. The advanced wound care and ostomy markets are serviced by companies such as Johnson & Johnson Medical, Arlington, Texas; ConvaTec, Skillman, N.J., a division of Bristol-Myers Squibb Co.; Coloplast, Inc. Marietta, GA; Cymed Ostomey Co., Berkeley, CA; Hollister Corp., Libertyville, IL; 3M Health Care, St. Paul, Minn.; Smith & Nephew, Memphis, Tenn.; and Kendall Healthcare Co., Mansfield, Mass, a division of Tyco International. "We are unique in our industry. We provide a technology that is desperately needed by physicians and care givers. Our MD@Hand, which is furnished to care givers free of charge as a component of our overall distribution strategy, will allow Instacare to aggressively expand its national footprint. We are confident that we have adopted a fundamentally sound business and market strategy," Mr. Berman continued. "And we believe that it will expand our ability to deliver affordable prescriptions, diagnostics and wound care products nationwide." Safe Harbor Statement This release contains forward-looking statements about our business or financial condition that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions. For further information, please contact: Carla Hintz, The Wells Group, (480) 391-7400 or visit the company's Web Site: www.instacare.net.
SOURCE Instacare Corp.